Assingments % - Schizophrenia Case Study: Assessment, Treatment, and Nursing Considerations

Vital Signs: HR 76, RR 14 BP 130/98, Temp 100.0 oral, O2 sat-92%

Introduction:

Maggie is a 27 year old. Filipina single woman, accompanied by an aunt and uncle with whom she lives.

Chief Complaint:

” I have schizophrenia and I need my medications ordered.”

History of Chief Complaint:

The psychiatrist who has been treating the patient does not take her insurance any longer, so she needs a new provider. She has been taking olanzapine 15 milligrams daily.

Past Psychiatric History:

Maggy started hearing voices as a freshman in college. Initially, the voices were just chattering, but then started saying they were going to hurt her. She said. I thought people were stalking me. She was treated by a psychiatrist. With that helped. She thought that she

was fine and stopped taking the lawns of pain. She relaxed and was hospitalized and was prescribed risperidone before being discharged, but she could not sleep. She was prescribed a variety of antipsychotic medication ( ziprasidone, aripiprazole, quetiapine). They did not control the paranoid thinking and the voices were loud and threatening. Eventually, She was prescribed olanzapine again, which she described as the most effective.

This is an unfolding case study which we will be utilizing for this discussion

Questions:

Based on your readings and in regards to Maggy’s history what additional questions do you have? Provide rationale for each question.(Have at least 3)
As a nurse working in a clinic what important aspects of schizophrenia do you need to consider? What if the physician will not prescribe the desired medication? (Elaborate on at least 3 concepts)
Explain the etiology of schizophrenia to the nursing student. Include any cultural considerations. (Elaborate on at least 3 concepts)
Explore and explain the concept of Psychopharmacology and Schizophrenia
Discuss with Maggy current modes of treatment and the role of the family related to Schizophrenia (Elaborate on at least 3 concepts)
Add a Module 12 PHARMACOLOGICALquestion: Can be for MDD or Bipolar disorder. After you have analyzed the content from the discussion board, please add a question to the end of your initial post regarding the reading material for the week.

Please be sure to validate your opinions and ideas with citations and references.

Responses need to address all components of the question, demonstrate critical thinking and analysis, and include peer-reviewed journal evidence to support the student’s position.

Struggling with where to start this assignment? Follow this guide to tackle your assignment easily!

🧠 Step-by-Step Guide for Completing This Discussion Assignment

This assignment centers on clinical reasoning, nursing assessment, cultural competence, and psychopharmacological treatment of schizophrenia. You’ll apply critical thinking skills to analyze Maggy’s case, pose thoughtful questions, and support your responses with peer-reviewed evidence.

📌 Section 1: Additional Questions for Maggy (With Rationale)

You need to formulate at least three clinical questions that will help gather more information about her psychiatric condition and history. For each, provide a clear rationale.

🔹Question 1:

“Have you experienced any recent changes in your mood, such as increased sadness, irritability, or manic symptoms?”
Rationale: Mood disorders can be comorbid with schizophrenia. Assessing for depressive or bipolar symptoms may inform differential diagnosis or treatment modifications (American Psychiatric Association, 2022).

🔹Question 2:

“Are you currently hearing voices or experiencing any delusions or paranoia?”
Rationale: Assessing the current severity of her psychotic symptoms is crucial for evaluating relapse or stability, especially as she is currently off her medication (Sadock, Sadock, & Ruiz, 2015).

🔹Question 3:

“Have you ever experienced any side effects from olanzapine or other antipsychotics, such as weight gain, sedation, or metabolic issues?”
Rationale: Olanzapine is associated with significant metabolic side effects. Understanding her side effect history can guide future treatment options (Correll et al., 2020).

📌 Section 2: Nursing Considerations for Schizophrenia (If Medication Not Prescribed)

As a clinic nurse, consider the following key points:

🔹1. Continuity of Care

If the physician refuses to prescribe olanzapine, it’s critical to ensure medication continuity to prevent relapse. You should advocate for a therapeutic alternative and help coordinate care to avoid hospitalization (NAMI, 2021).

🔹2. Patient Advocacy

Nurses act as liaisons between patients and providers. Advocate for a shared decision-making process, respecting Maggy’s insight into what medication works best for her (Townsend & Morgan, 2022).

🔹3. Medication Adherence and Side Effect Education

Many patients discontinue antipsychotics due to side effects. Educating Maggy about the risk-benefit balance of each option can empower her to participate actively in treatment decisions (Muench & Hamer, 2010).

📌 Section 3: Etiology and Cultural Considerations

Teach the nursing student the biopsychosocial and cultural aspects of schizophrenia’s origin.

🔹1. Biological Factors

Schizophrenia has a strong genetic component, with dysregulation of neurotransmitters like dopamine and glutamate contributing to symptomatology (Howes & Murray, 2014).

🔹2. Environmental Triggers

Prenatal complications, stress, and drug use (e.g., cannabis) can exacerbate or trigger onset, especially in genetically predisposed individuals (Tandon et al., 2009).

🔹3. Cultural Beliefs

In Filipino culture, mental illness may be stigmatized or attributed to supernatural causes. This may delay treatment or discourage medication adherence, making cultural sensitivity and family involvement essential (Sanchez & Gaw, 2007).

📌 Section 4: Psychopharmacology and Schizophrenia

Psychopharmacology is the study of how drugs affect mood, behavior, and mental processes.

Key Points:

Antipsychotics are the mainstay of schizophrenia treatment. First-generation (typical) antipsychotics primarily block dopamine D2 receptors. Second-generation (atypical) agents like olanzapine have broader neurotransmitter action and fewer extrapyramidal side effects (Lieberman et al., 2005).
Olanzapine is effective for treatment-resistant schizophrenia but requires monitoring for metabolic syndrome, including weight, cholesterol, and blood glucose.
Pharmacologic strategies must be individualized, balancing efficacy with side effects, and integrating patient preferences.

📌 Section 5: Discussing Treatment and Family Role with Maggy

🔹1. Current Treatment Options

Discuss options like:

Second-generation antipsychotics (e.g., olanzapine, aripiprazole)
Long-acting injectable antipsychotics for non-adherence
Cognitive Behavioral Therapy for psychosis (CBTp)

🔹2. Family Involvement

Family psychoeducation helps reduce relapse and hospitalizations. Maggy’s aunt and uncle can provide emotional support, help monitor symptoms, and ensure medication adherence (Dixon et al., 2001).

🔹3. Lifestyle and Support Services

Encourage use of community resources, vocational rehab, peer support, and structured routines. Recovery is not only pharmacologic—it’s psychosocial too.

📌 Section 6: Module 12 Pharmacology Question (for Discussion Board)

What are the clinical differences between treating Major Depressive Disorder and Bipolar Disorder with antidepressants, and what are the risks of prescribing SSRIs without mood stabilizers in bipolar patients?

✅ Final Reminders

Support every claim with peer-reviewed sources.
Demonstrate critical thinking, not just summarization.
Keep the tone professional and analytical, suitable for a clinical nursing course.

📚 References

American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.).
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2020). Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia. World Psychiatry, 19(2), 162–180.
Dixon, L., et al. (2001). Evidence-based practices for services to families of people with psychiatric disabilities. Psychiatric Services, 52(7), 903–910.
Howes, O. D., & Murray, R. M. (2014). Schizophrenia: An integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677–1687.
Lieberman, J. A., et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. NEJM, 353(12), 1209–1223.
Muench, J., & Hamer, A. M. (2010). Adverse effects of antipsychotic medications. American Family Physician, 81(5), 617–622.
NAMI. (2021). Schizophrenia. https://www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Schizophrenia
Sanchez, F., & Gaw, A. (2007). Mental health care of Filipino Americans. Psychiatric Services, 58(6), 810–815.
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009). Schizophrenia: “Just the facts” 5. Treatment and prevention. Schizophrenia Research, 110(1-3), 1–23.
Townsend, M. C., & Morgan, K. I. (2022). Psychiatric Mental Health Nursing: Concepts of Care in Evidence-Based Practice. F.A. Davis Company.